Skip to main content

Use of Dexmedetomidine in a Parturient With Multiple Endocrine Neoplasia Type 2A Undergoing Adrenalectomy and Thyroidectomy: A Case Report.

Publication ,  Journal Article
Faulkner, AL; Swanson, E; McLarney, TL; Lee, CY; Rebel, A
Published in: A A Pract
March 1, 2019

Dexmedetomidine is a selective α2-agonist, frequently used in perioperative medicine as anesthesia adjunct. The medication carries a Food and Drug Administration pregnancy category C designation and is therefore rarely used for parturients undergoing nonobstetric surgery. We are reporting the use of dexmedetomidine in the anesthetic management of a parturient undergoing minimally invasive unilateral adrenalectomy for pheochromocytoma during the second trimester of pregnancy. Additionally, because of the multiple endocrine neoplasia type 2A constellation with diagnosis of medullary thyroid cancer, the patient underwent a total thyroidectomy 1 week after the adrenalectomy.

Duke Scholars

Published In

A A Pract

DOI

EISSN

2575-3126

Publication Date

March 1, 2019

Volume

12

Issue

5

Start / End Page

136 / 140

Location

United States

Related Subject Headings

  • Thyroidectomy
  • Thyroid Neoplasms
  • Pregnancy Complications, Neoplastic
  • Pregnancy
  • Pheochromocytoma
  • Multiple Endocrine Neoplasia Type 2a
  • Humans
  • Female
  • Dexmedetomidine
  • Carcinoma, Neuroendocrine
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Faulkner, A. L., Swanson, E., McLarney, T. L., Lee, C. Y., & Rebel, A. (2019). Use of Dexmedetomidine in a Parturient With Multiple Endocrine Neoplasia Type 2A Undergoing Adrenalectomy and Thyroidectomy: A Case Report. A A Pract, 12(5), 136–140. https://doi.org/10.1213/XAA.0000000000000861
Faulkner, Amanda L., Eric Swanson, Thomas L. McLarney, Cortney Y. Lee, and Annette Rebel. “Use of Dexmedetomidine in a Parturient With Multiple Endocrine Neoplasia Type 2A Undergoing Adrenalectomy and Thyroidectomy: A Case Report.A A Pract 12, no. 5 (March 1, 2019): 136–40. https://doi.org/10.1213/XAA.0000000000000861.
Faulkner, Amanda L., et al. “Use of Dexmedetomidine in a Parturient With Multiple Endocrine Neoplasia Type 2A Undergoing Adrenalectomy and Thyroidectomy: A Case Report.A A Pract, vol. 12, no. 5, Mar. 2019, pp. 136–40. Pubmed, doi:10.1213/XAA.0000000000000861.
Faulkner AL, Swanson E, McLarney TL, Lee CY, Rebel A. Use of Dexmedetomidine in a Parturient With Multiple Endocrine Neoplasia Type 2A Undergoing Adrenalectomy and Thyroidectomy: A Case Report. A A Pract. 2019 Mar 1;12(5):136–140.

Published In

A A Pract

DOI

EISSN

2575-3126

Publication Date

March 1, 2019

Volume

12

Issue

5

Start / End Page

136 / 140

Location

United States

Related Subject Headings

  • Thyroidectomy
  • Thyroid Neoplasms
  • Pregnancy Complications, Neoplastic
  • Pregnancy
  • Pheochromocytoma
  • Multiple Endocrine Neoplasia Type 2a
  • Humans
  • Female
  • Dexmedetomidine
  • Carcinoma, Neuroendocrine